Interacting Drugs |
Ketoconazole (systemic) vs Rivaroxaban |
Security Level |
|
Mechanism |
Rivaroxaban: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Rivaroxaban. |
Management |
Monitor therapy |
Ketoconazole (systemic) vs Rivaroxaban
Post Review about Ketoconazole (systemic) vs Rivaroxaban Click here to cancel reply.
Other Interactions of Ketoconazole (systemic)
Ketoconazole (systemic) vs Rivaroxaban
Interacting Drugs |
Ketoconazole (systemic) vs Rivaroxaban |
Security Level |
|
Mechanism |
Rivaroxaban: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Rivaroxaban. |
Management |
Avoid combination |
No comments yet.
Post Review about Ketoconazole (systemic) vs Rivaroxaban Click here to cancel reply.
Other Interactions of Ketoconazole (systemic)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.